Home > Healthcare > Medical Devices > Implantable Devices > Cardiac Prosthetic Devices Market

Cardiac Prosthetic Devices Market Size

  • Report ID: GMI1965
  • Published Date: Nov 2024
  • Report Format: PDF

Cardiac Prosthetic Devices Market Size

The global cardiac prosthetic devices market size was valued at USD 8.6 billion in 2024 and is expected to exhibit growth at a CAGR of 8.4% from 2025 to 2034. High market growth can be attributed to continuous technological advancements in medical devices, rising prevalence of cardiovascular diseases, growing geriatric population, and increasing adoption of minimally invasive procedures, among other contributing factors.

 

Moreover, the aging population is more susceptible to heart-related ailments, creating demand for cardiac devices. For instance, according to a recent United Nations (UN) research report, the number of people aged 65 and over globally is predicted to triple over the next three decades. The senior population is expected to reach 1.6 billion by 2050, accounting for more than 16% of the global population. Elderly patients are often at higher risk for heart valve diseases and may require interventions like heart valve replacements and other cardiac prosthetic devices.
 

Furthermore, innovations in materials, device designs, and minimally invasive implantation techniques have improved the performance and safety of cardiac prosthetic devices. For example, developments in transcatheter aortic valve replacement (TAVR) devices make them suitable for patients who are high-risk for open-heart surgery.
 

Cardiac prosthetic devices are artificial devices implanted in the heart or related cardiovascular structures to replace or support the function of damaged or diseased heart components. These devices are primarily used to treat severe heart conditions or abnormalities that cannot be managed through medication or less invasive treatments.
 

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The global cardiac prosthetic devices industry was valued at USD 8.6 billion in 2024 and is expected to grow at a CAGR of 8.4% from 2025 to 2034, driven by continuous technological advancements in medical devices.

The pacemaker segment generated USD 5.7 million in 2024, driven by the rising incidence of arrhythmias, including bradycardia, atrial fibrillation, and heart block.

The North America cardiac prosthetic devices market recorded USD 3.7 billion in 2024 and is anticipated to grow at a CAGR of 7.7% between 2025 and 2034, led by a high burden of cardiovascular diseases and contributing lifestyle factors.

Key players in the industry include Abbott Laboratories, Abiomed, AtriCure, Biotronik, Boston Scientific Corporation, CryoLife, Edwards Lifesciences Corporation, Labcor Laborat

Cardiac Prosthetic Devices Market Scope

Buy Now


Premium Report Details

  • Base Year: 2024
  • Companies covered: 15
  • Tables & Figures: 259
  • Countries covered: 20
  • Pages: 160
 Download Free Sample